期刊文献+

伊布利特治疗心房扑动、心房颤动临床疗效观察 被引量:1

Clinical observation of ibutilide for the termination of atrial flutter and atrial fibrillation
下载PDF
导出
摘要 目的观察伊布利特治疗心房扑动(房扑)、心房颤动(房颤)的疗效。方法32例房扑、房颤患者予以静脉注射伊布利特(1 mg1~2次,每次10 min)治疗,观察转复为窦性心律的疗效。结果伊布利特治疗房扑、房颤转复为窦性心律的成功率分别是83.3%和50%。结论伊布利特转复房扑、房颤疗效确切。 Objective To observe efficacy and safety of intravenous ibutilide for treatment of atrial fibrillation and atrial flutter.Methods A total of 32 patients with atrial fibrillation or atrial flutter were assigned to receive infusion of ibutilide(1 or 2 times,1.0 mg for each).Results The success rates of stopping atrial fibrillation and atrial flutter with ibutilide were 83.3%and 50%.Conclusion Ibutilide can rapidly,safely and effectively terminate atrial fibrillation or atrial flutter.
出处 《中国实用医药》 2010年第9期31-32,共2页 China Practical Medicine
关键词 伊布利特 心房扑动 心房颤动 Ibutilide Atrial flutter Atrial fibrillation
  • 相关文献

参考文献7

二级参考文献23

  • 1Gowda RM, Punukotlu G, Khan IA, et al. Ibutilide for pharmacological cardioversion of atrial fibrillation and flutter: impact of race on efficacy and safety. Am J Ther,2003,10:259-263.
  • 2Antonicelli R, Testarmata P, Recanatini A. lbutilide in rapid conversion of atrial flutter in octogenarians. Drugs Aging, 2002, 19:787-791.
  • 3Gowda RM, Punukollu G, Khan IA, et al. lbutilide for pharmacological cardioversion of atrial fibrillation and flutter: impact of race on efficacy and safety. Am J Ther, 2003, 10: 259-263.
  • 4Cheng J, Glatter K, Yang Y, et al. Electrophysiological response of the right atrium to ibutilide during typical atrial flutter. Circulation, 2002,106:814-819.
  • 5Kafkas NV, Patsilinakos SP, Mertzanos GA,et al. Conversion efficacy of intravenous ibutilide compared with intravenous amiodalone in patients with recent-onset atrial fibrillation and atrial flutter. Int J Cardiol,2007 ,118 :321-325.
  • 6Eidher U, Freihoff F, Kaltenbrunner W, el al. Efficacy and safety of ibutilide for the conversion of monomorphic atrial tachycardia. Pacing Clin Electrophysiol, 2006,29 : 358-362.
  • 7Hongo RH, Themistoclakis S, Raviele A, et al. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents. J Am Coll Cardiol,2004,4d-:86d-- 868.
  • 8Rodriguez I, Kilbom MJ, Liu XK,et al. Drug-induced QT prolongation in women during the menstrual cycle. JAMA,2001, 285 : 1322-1326.
  • 9Kowey PR, Vanderlugt JT, Luderer JR. Safety and risk /benefit analysis of ibutilide for acute conversion of atrial fibrillation/flutter. Am J Cardiol, 1996,78: 46-52.
  • 10Wijffels ME, Kirchof CJ, Dorland R, et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats[J].Circulation, 1995 ;92:1954 - 1968.

共引文献24

同被引文献3

  • 1张海澄,郭继鸿,方全,郑亚安,孙跃民,朱文青,万征,郭静萱,葛均波,韩少梅.静脉注射伊布利特与普罗帕酮转复心房颤动和扑动的多中心研究[J].中华医学杂志,2005,85(12):798-801. 被引量:43
  • 2Fuster V, Ryden LE, Cannom DS, et at. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the man- agement of patients with atrial fibrillation: a report of the American college of cardiology Fotmdafion/Americml heart association task force on practice guidelines developed in partnership with the European society of cardiology and in collaboration with the European hem~ rhythm association and the heart rhythm society[J]. J Am Coil Cardiol,2011,57(11) :101 - 198.
  • 3Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the european society of cardiology (ESC) [ J]. Eur Heart J, 2010,31 (19) : 2369 - 2429.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部